![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print February 13, 2001
Pharmacology & Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721-0207
Corresponding Author: regan{at}pharmacy.arizona.edu
FP prostanoid receptors are G-protein coupled receptors (GPCR) that consist of two known isoforms named FPA and FPB. These isoforms, which are generated by alternative mRNA splicing, are identical except for their carboxyl terminal domains. Previously we have shown that stimulation of both isoforms with prostaglandin F2{alpha} (PGF2{alpha}) activates the small G-protein, Rho, leading to morphological changes consisting of cell rounding and the formation of cell aggregates. Following the removal of PGF2{alpha}, however, FPA expressing cells show rapid reversal of cell rounding, whereas FPB expressing cells do not. We now show that acute treatment of FPB expressing cells with PGF2{alpha} leads to a subcellular reorganization of
J. Biol. Chem, 10.1074/jbc.C100039200
Submitted on January 24, 2001
Revised on February 13, 2001
Accepted on February 13, 2001
FP prostanoid receptor activation of a Tcf/beta-catenin signaling pathway
-catenin, a decrease in the phosphorylation of cytoplasmic
-catenin, and persistent stimulation of Tcf/Lef mediated transcriptional activation. This does not occur in FPA expressing cells and may underlie the differences between these isoforms with respect to the reversal of cell rounding. The Tcf/
-catenin signaling pathway is known to mediate the actions of Wnt acting through the heptahelical receptor, Frizzled, and has not been previously associated with GPCR activation. Our findings expand the signaling possibilities for GPCRs and suggest novel roles for FP receptors in normal tissue development and malignant transformation.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Gardner, S. Maudsley, R. P. Millar, and A. J. Pawson Nuclear Stabilization of {beta}-Catenin and Inactivation of Glycogen Synthase Kinase-3{beta} by Gonadotropin-Releasing Hormone: Targeting Wnt Signaling in the Pituitary Gonadotrope Mol. Endocrinol., December 1, 2007; 21(12): 3028 - 3038. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Alfranca, M. A. Iniguez, M. Fresno, and J. M. Redondo Prostanoid signal transduction and gene expression in the endothelium: Role in cardiovascular diseases Cardiovasc Res, June 1, 2006; 70(3): 446 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yan and H.-H. Tai Glycogen Synthase Kinase-3 Phosphorylation, T-Cell Factor Signaling Activation, and Cell Morphology Change following Stimulation of Thromboxane Receptor {alpha} J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 267 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yang, W. W. Zhong, N. Srivastava, A. Slavin, J. Yang, T. Hoey, and S. An G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the {beta}-catenin pathway PNAS, April 26, 2005; 102(17): 6027 - 6032. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fujino, G. A. Vielhauer, and J. W. Regan Prostaglandin E2 Selectively Antagonizes Prostaglandin F2{alpha}-stimulated T-cell Factor/{beta}-Catenin Signaling Pathway by the FPB Prostanoid Receptor J. Biol. Chem., October 15, 2004; 279(42): 43386 - 43391. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kuhnert, C. R. Davis, H.-T. Wang, P. Chu, M. Lee, J. Yuan, R. Nusse, and C. J. Kuo Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1 PNAS, January 6, 2004; 101(1): 266 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Diks, J. C. Hardwick, R. M. Diab, M. M. van Santen, H. H. Versteeg, S. J. H. van Deventer, D. J. Richel, and M. P. Peppelenbosch Activation of the Canonical {beta}-Catenin Pathway by Histamine J. Biol. Chem., December 26, 2003; 278(52): 52491 - 52496. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Saito, Y. Guan, Z. Qi, L. S. Davis, M. Komhoff, Y. Sugimoto, S. Narumiya, R. M. Breyer, and M. D. Breyer Expression of the prostaglandin F receptor (FP) gene along the mouse genitourinary tract Am J Physiol Renal Physiol, June 1, 2003; 284(6): F1164 - F1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fujino, W. Xu, and J. W. Regan Prostaglandin E2 Induced Functional Expression of Early Growth Response Factor-1 by EP4, but Not EP2, Prostanoid Receptors via the Phosphatidylinositol 3-Kinase and Extracellular Signal-regulated Kinases J. Biol. Chem., March 28, 2003; 278(14): 12151 - 12156. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fujino, D. Srinivasan, and J. W. Regan Cellular Conditioning and Activation of beta -Catenin Signaling by the FPB Prostanoid Receptor J. Biol. Chem., December 6, 2002; 277(50): 48786 - 48795. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Srinivasan, H. Fujino, and J. W. Regan Differential Internalization of the Prostaglandin F2alpha Receptor Isoforms: Role of Protein Kinase C and Clathrin J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 219 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Meigs, M. Fedor-Chaiken, D. D. Kaplan, R. Brackenbury, and P. J. Casey Galpha 12 and Galpha 13 Negatively Regulate the Adhesive Functions of Cadherin J. Biol. Chem., June 28, 2002; 277(27): 24594 - 24600. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen, L. A. Hu, M. V. Semenov, S. Yanagawa, A. Kikuchi, R. J. Lefkowitz, and W. E. Miller beta -Arrestin1 modulates lymphoid enhancer factor transcriptional activity through interaction with phosphorylated dishevelled proteins PNAS, December 6, 2001; (2001) 211572798. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Kaplan, T. E. Meigs, and P. J. Casey Distinct Regions of the Cadherin Cytoplasmic Domain Are Essential for Functional Interaction with Galpha 12 and beta -Catenin J. Biol. Chem., November 16, 2001; 276(47): 44037 - 44043. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fujino, K. A. West, and J. W. Regan Phosphorylation of Glycogen Synthase Kinase-3 and Stimulation of T-cell Factor Signaling following Activation of EP2 and EP4 Prostanoid Receptors by Prostaglandin E2 J. Biol. Chem., January 18, 2002; 277(4): 2614 - 2619. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen, L. A. Hu, M. V. Semenov, S. Yanagawa, A. Kikuchi, R. J. Lefkowitz, and W. E. Miller beta -Arrestin1 modulates lymphoid enhancer factor transcriptional activity through interaction with phosphorylated dishevelled proteins PNAS, December 18, 2001; 98(26): 14889 - 14894. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |